At baseline, HCC patients had lower levels of serum albumin, but higher values of alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, bilirubin and α-foetoprotein than those of chronic carriers (P < 0.001 for all comparisons). This evidence concerns the gene ALB and hepatocellular carcinoma.